title: Prevalence of diabetes in care home residents.
abstract: OBJECTIVE
  To determine the prevalence of known and undetected diabetes diagnosed either by an elevated fasting baseline sample or by a 2-h post-glucose load sample in a group of residents of care homes in an urban-district setting.
  
  
  METHODS
  We completed individual interviews with patients and caregivers in 30 care homes (both residential and nursing homes) in two metropolitan districts of Birmingham, West Midlands, U.K. All care homes were under the supervision of primary care physicians (general practitioners). We carried out 75-g oral glucose tolerance tests (OGTTs) in consenting residents without previous known diabetes. Criteria for diagnosis of diabetes were obtained from the World Health Organization (1998) and the American Diabetes Association (1997).
  
  
  RESULTS
  Of 636 residents available for study, 76 residents (12.0%) were known to have diabetes; of the 560 remaining residents, 286 either refused to participate or were deemed too ill or unavailable to undergo testing. Complete data on 274 OGTTs were obtained (median age 83 years, range 45-101). A total of 46 subjects were diagnosed as having diabetes and 94 as having impaired glucose tolerance. Allowing for subjects who refused or were unable to participate, the calculated total prevalence (which includes known and newly detected diabetes) was 26.7% (95% CI 21.9-32.0). The calculated overall prevalence of impaired glucose tolerance was 30.2% (25.2-35.6).
  
  
  CONCLUSIONS
  In a group of care home residents not known to have diabetes and able to undergo testing, a substantial proportion have undetected diabetes based on a 2-h postglucose load. These residents warrant further study as they may be at higher cardiovascular risk and require an intervention.
authors.affiliation: Diabetes Research Unit, Selly Oak Hospital, University of Birmingham, Bimingham, U.K. a.j.sinclair@bham.ac.uk
authors.forename: A J
authors.initials: AJ
authors.lastname: Sinclair
authors.forename: R
authors.initials: R
authors.lastname: Gadsby
authors.forename: S
authors.initials: S
authors.lastname: Penfold
authors.forename: S C
authors.initials: SC
authors.lastname: Croxson
authors.forename: A J
authors.initials: AJ
authors.lastname: Bayer
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000453:epidemiology*; D004739:England / Q000453:epidemiology; D005194:Family Practice; D018149:Glucose Intolerance / Q000175:diagnosis / Q000453:epidemiology*; D005951:Glucose Tolerance Test; D006801:Humans; D008875:Middle Aged; D009735:Nursing Homes / Q000706:statistics & numerical data; D010358:Patient Participation; D015995:Prevalence; D012112:Residential Facilities / Q000706:statistics & numerical data*; D016312:Treatment Refusal; D014505:Urban Population
chemical_list: D001786:Blood Glucose